<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02796989</url>
  </required_header>
  <id_info>
    <org_study_id>s58346</org_study_id>
    <nct_id>NCT02796989</nct_id>
  </id_info>
  <brief_title>The Impact of Modified Wheat Bran on Carbohydrate Fermentation in the Colon in Healthy and Obese Subjects</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>Katholieke Universiteit Leuven</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Katholieke Universiteit Leuven</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      During this project the effect of modified wheat bran on colon health and systemic health
      will be evaluated in a long-term intervention study in healthy and obese subjects.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>March 2016</start_date>
  <completion_date type="Actual">December 2017</completion_date>
  <primary_completion_date type="Actual">December 2017</primary_completion_date>
  <phase>Phase 1/Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>The incremental plasma short-chain fatty acid concentrations will be measured using GC-FID after an intervention with wheat bran/placebo</measure>
    <time_frame>2 years</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Changes in glucose levels (mg/dL)</measure>
    <time_frame>2 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes in insulin levels (pmol/L)</measure>
    <time_frame>2 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes in cholesterol levels (mg/dL)</measure>
    <time_frame>2 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes in free fatty acids levels (mmol/L)</measure>
    <time_frame>2 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes in triglyceride levels (mg/dL)</measure>
    <time_frame>2 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Gut permeability using 51-Cr-EDTA</measure>
    <time_frame>2 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Total gastrointestinal transit time</measure>
    <time_frame>2 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes in gut microbiota before and after the intervention using 16S rRNA sequencing</measure>
    <time_frame>2 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes in metabolite patterns in the feces before and after the intervention using gas chromatography coupled to mass spectrometry</measure>
    <time_frame>2 years</time_frame>
  </secondary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Actual">50</enrollment>
  <condition>Healthy</condition>
  <condition>Obese</condition>
  <arm_group>
    <arm_group_label>Healthy - Wheat Bran</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Wheat bran 20 g each day</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Healthy - Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Placebo 20 g each day</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Obese - Wheat bran</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Wheat bran 20 g each day</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Obese - Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Placebo 20 g each day</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Wheat bran</intervention_name>
    <description>20 g each day</description>
    <arm_group_label>Healthy - Wheat Bran</arm_group_label>
    <arm_group_label>Obese - Wheat bran</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>20 g each day</description>
    <arm_group_label>Healthy - Placebo</arm_group_label>
    <arm_group_label>Obese - Placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Aged between 18 and 65 years old

          -  BMI between 18 and 25 kg/m² OR higher than 30 kg/m²

          -  Regular diet

          -  Not dieting

        Exclusion Criteria:

          -  Use of antibiotics in the month preceding the study

          -  Diabetes Type 1 or 2

          -  Abdominal surgery (except from appendectomy)

          -  Use of medication that affects the gastrointestinal tract during the last 2 weeks
             prior to the study including spasmolytics, anti-diarrhoea medication,
             anti-constipation medication

          -  Use of pre- or probiotic supplements in the month preceding the study

          -  Chronic gastrointestinal diseases, such as inflammatory bowel disease (Crohn's
             disease, ulcerative colitis), irritable bowel disease…

          -  Pregnancy or lactation

          -  Blood donation in the last 3 months

          -  Abnormal Hb-level (Standard range between 14 and 18 g/dL for men and between 12 and 16
             g/dL for women)

          -  Participation in clinical studies involving radiation exposure in the past year
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>KU Leuven</name>
      <address>
        <city>Leuven</city>
        <state>Vlaams-Brabant</state>
        <zip>3000</zip>
        <country>Belgium</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Belgium</country>
  </location_countries>
  <verification_date>January 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 27, 2016</study_first_submitted>
  <study_first_submitted_qc>June 10, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 13, 2016</study_first_posted>
  <last_update_submitted>January 26, 2018</last_update_submitted>
  <last_update_submitted_qc>January 26, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">January 29, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Katholieke Universiteit Leuven</investigator_affiliation>
    <investigator_full_name>Kristin Verbeke</investigator_full_name>
    <investigator_title>Professor Kristin Verbeke</investigator_title>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

